Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19.

ABSTRACT:

Background

Previous studies have reported on myocardial injury in patients with coronavirus infectious disease 19 (COVID-19) defined as elevated cardiac biomarkers. Whether elevated biomarkers truly represent myocardial dysfunction is not known. The aim of this study was to explore the incidence of ventricular dysfunction and assess its relationship with biomarker analyses.

Methods

This cross-sectional study ran from April 1 to May 12, 2020, and consisted of all consecutively admitted patients to the Radboud university medical centre nursing ward for COVID-19. Laboratory assessment included high-sensitivity Troponin T and N‑terminal pro-B-type natriuretic peptide (NT-proBNP). Echocardiographic evaluation focused on left and right ventricular systolic function and global long

SUBMITTER: van den Heuvel FMA 

PROVIDER: S-EPMC7341471 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature